SK pharmteco today announced the launch of SKyvec™, its proprietary, multimodal viral vector platform. Designed to support ...

What is collectively needed, both companies maintain, are more efficient, safer, and scalable approaches to cell engineering.

On track for enrollment of 80 participants by Q1 2027Trial is supported by Phase 2 results showing significant improvement in overall survival in ...

VectorBuilder, a global leader in gene delivery technologies and CDMO services, and MaxCyte, a leading, cell-engineering ...

Includes up-front issuance of preferred stock for $2.5 million and secured promissory notes for $7.72 millionUniquely structured, flexible ...

A research team led by Park Ji-hoon at the Korea Research Institute of Chemical Technology has developed a new gene delivery ...

A dual-organism therapy uses engineered bacteria to deliver an oncolytic virus into tumors, triggering cell death and immune ...

We use the AdenoX Rapid Titer kit (Clontech now Takara Bio) for this service. This immunohistochemical assay involves making 3 serials dilutions of the virus and infecting 6 wells of a 24-well plate ...

June 15, 2026 – 4basebio PLC (AIM: 4BB), a specialist in specialist in synthetic DNA manufacturing for next-generation genomic medicines and advanced therapies, today announces the appointment of Jeff ...

Shanghai, China - On March 18, 2026, Frost & Sullivan and Forbes China Group jointly hosted the 2026 FORBES CHINA PIONEER ...

The viral type 2 internal ribosome entry site uses a unique mechanism to hijack the host ribosomal machinery by interacting with initiator tRNA and 40S head.

Despicable Me took the world by storm in 2010, proving that new animation studios could emerge from the shadows and release successful projects worthy of sharing the spotlight with juggernauts like ...